筛查超声检出的乳腺癌:生存率及与复发相关的临床病理和影像因素
回顾性纳入四家机构501例筛查超声检出的乳腺癌(425例浸润癌、76例导管原位癌),中位随访7.0年,5年总生存率100%、无复发生存率98.0%(95%CI 96.8%, 99.2%)。浸润癌中年龄小于40岁、三阴性亚型、BI-RADS 4A类病变与复发相关。
要点
- 筛查超声检出乳腺癌的5年无复发生存率98.0%,总生存率100%。
- 浸润癌复发相关因素:年龄小于40岁、三阴性亚型、BI-RADS 4A类病变。
- 随访期间复发15例(3.0%),其中同侧乳腺5例、对侧乳腺10例。
核心结论
- 筛查超声检出的乳腺癌患者结局良好,5年无复发生存率98.0%;浸润癌中年龄小于40岁、三阴性亚型和BI-RADS 4A类病变与复发相关。
研究设计与样本
- 回顾性研究,纳入四家机构2004年1月至2011年3月筛查超声检出的501例乳腺癌女性(中位年龄47岁,范围27-74岁;425例浸润癌、76例导管原位癌),采用Cox比例风险回归进行多因素分析。
诊断标准与关键数值
- 5年总生存率100%,5年无复发生存率98.0%(95%CI 96.8%, 99.2%)。
- 浸润癌中年龄小于40岁与复发相关(HR 3.632,95%CI 1.099, 11.998;P = .032)。
- 浸润癌中三阴性亚型与复发相关(HR 7.498,95%CI 2.266, 24.816;P = .001)。
- 浸润癌中BI-RADS 4A类病变与复发相关(HR 5.113,95%CI 1.532, 17.195;P = .008)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine the survival rates and clinical-pathologic and imaging factors associated with recurrence in women with breast cancer detected at screening ultrasonography (US). Materials and Methods This study was approved by the institutional review board, and the requirement to obtain informed consent was waived. A retrospective review of the databases of four institutions identified 501 women (median age, 47 years; range, 27-74 years) with breast cancer (425 invasive cancers and 76 ductal carcinoma in situ) detected at screening US between January 2004 and March 2011. Five-year overall survival (OS) and recurrence-free survival (RFS) rates were estimated, and the clinical-pathologic and imaging data were collected. Multivariate analysis was performed by using Cox proportional hazard regression to determine factors associated with recurrence. Results At a median follow-up of 7.0 years (range, 5.0-12.1 years), 15 (3.0%) recurrences were detected: five in ipsilateral breast and 10 in contralateral breast. The 5-year OS and RFS rates were 100% and 98.0% (95% confidence interval [CI]: 96.8%, 99.2%), respectively. In patients with invasive cancers, age younger than 40 years (hazard ratio: 3.632 [95% CI: 1.099, 11.998]; P = .032), the triple-negative subtype (hazard ratio: 7.498 [95% CI: 2.266, 24.816]; P = .001), and Breast Imaging Reporting and Data System (BI-RADS) category 4A lesions (hazard ratio: 5.113 [95% CI: 1.532, 17.195]; P = .008) were associated with recurrence. Conclusion Women with breast cancers detected at screening US have excellent outcomes, with a 5-year RFS rate of 98.0%. However, in patients with invasive breast cancer, age younger than 40 years, the triple-negative subtype, and BI-RADS category 4A lesions were associated with recurrence. © RSNA, 2017 Online supplemental material is available for this article.
引用
- Kim SY, Han BK, Kim EK, et al. Breast Cancer Detected at Screening US: Survival Rates and Clinical-Pathologic and Imaging Factors Associated with Recurrence. Radiology. 2017. PMID: 28387638. doi:10.1148/radiol.2017162348
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。